Atricure, Inc. (ATRC) Tops Q2 EPS by 3c, Boosts FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Piper Jaffray Raises Price Target on Atricure, Inc. (ATRC) to $30 Following 2Q Results
July 29, 2015 10:10 AM EDTPiper Jaffray reiterated an Overweight rating on AtriCure Inc. (NASDAQ: ATRC), and raised the price target to $30.00 (from $23.00), following 2Q15 results. ATRC reported Q2 sales of $32.6M, and EPS of -$0.18, beating out consensus on both metrics. Analyst Thomas Gunderson believes that... More
